Wells Fargo’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107 | Hold |
65
| – | – | ﹤0.01% | 6011 |
|
|
2025
Q1 | $103 | Hold |
65
| – | – | ﹤0.01% | 5903 |
|
|
2024
Q4 | $218 | Hold |
65
| – | – | ﹤0.01% | 5851 |
|
|
2024
Q3 | $122 | Hold |
65
| – | – | ﹤0.01% | 5852 |
|
|
2024
Q2 | $128 | Sell |
65
-109
| -63% | -$215 | ﹤0.01% | 5846 |
|
|
2024
Q1 | $535 | Buy |
174
+2
| +1% | +$6 | ﹤0.01% | 5872 |
|
|
2023
Q4 | $400 | Buy |
172
+67
| +64% | +$156 | ﹤0.01% | 5991 |
|
|
2023
Q3 | $424 | Buy |
105
+16
| +18% | +$65 | ﹤0.01% | 6022 |
|
|
2023
Q2 | $365 | Buy |
89
+2
| +2% | +$8 | ﹤0.01% | 6241 |
|
|
2023
Q1 | $268 | Hold |
87
| – | – | ﹤0.01% | 6375 |
|
|
2022
Q4 | $235 | Sell |
87
-55
| -39% | -$149 | ﹤0.01% | 6247 |
|
|
2022
Q3 | $0 | Buy |
142
+58
| +69% | – | ﹤0.01% | 7125 |
|
|
2022
Q2 | $0 | Buy |
84
+3
| +4% | – | ﹤0.01% | 7241 |
|
|
2022
Q1 | $1K | Hold |
81
| – | – | ﹤0.01% | 6520 |
|
|
2021
Q4 | $1K | Buy |
+81
| New | +$1K | ﹤0.01% | 6526 |
|
|
2021
Q2 | – | Sell |
-431
| Closed | -$53K | – | 7082 |
|
|
2021
Q1 | $53K | Sell |
431
-1,328
| -75% | -$163K | ﹤0.01% | 5444 |
|
|
2020
Q4 | $200K | Buy |
1,759
+240
| +16% | +$27.3K | ﹤0.01% | 4956 |
|
|
2020
Q3 | $181K | Sell |
1,519
-86
| -5% | -$10.2K | ﹤0.01% | 4837 |
|
|
2020
Q2 | $200K | Buy |
1,605
+861
| +116% | +$107K | ﹤0.01% | 4750 |
|
|
2020
Q1 | $143K | Buy |
744
+291
| +64% | +$55.9K | ﹤0.01% | 4700 |
|
|
2019
Q4 | $152K | Sell |
453
-19
| -4% | -$6.38K | ﹤0.01% | 4933 |
|
|
2019
Q3 | $152K | Buy |
472
+53
| +13% | +$17.1K | ﹤0.01% | 4912 |
|
|
2019
Q2 | $180K | Buy |
419
+92
| +28% | +$39.5K | ﹤0.01% | 4842 |
|
|
2019
Q1 | $184K | Buy |
327
+109
| +50% | +$61.3K | ﹤0.01% | 4794 |
|
|
2018
Q4 | $64K | Buy |
218
+197
| +938% | +$57.8K | ﹤0.01% | 5180 |
|
|
2018
Q3 | $15K | Buy |
21
+10
| +91% | +$7.14K | ﹤0.01% | 5533 |
|
|
2018
Q2 | $6K | Sell |
11
-3
| -21% | -$1.64K | ﹤0.01% | 5694 |
|
|
2018
Q1 | $38K | Buy |
+14
| New | +$38K | ﹤0.01% | 5336 |
|